Kuros Biosciences' Reverse Merger Round

Kuros Biosciences raised a round of funding on December 03, 2015. Investors include Cytos Biotechnology.

Kuros Biosciences (SIX:KURN), fka Kuros Biosurgery, is focused on the development of products for tissue repair and regeneration, notably sealants and orthobiologics.…

Articles about Kuros Biosciences' Reverse Merger Round: